Discovering and Developing Novel,
Oral, Small-Molecule Therapeutics
At Kallyope, we focus on big health challenges that matter to patients and families. We aim to discover and develop effective, easy to use, and well-tolerated oral agents addressing metabolic, neurological, and gastrointestinal diseases.
Inside every human body is a complex, unexplored network of metabolic, neurological, and gastrointestinal interconnections. Our scientists are unlocking the mysteries of this network to develop oral therapies for obesity and diabetes; neurological disorders, including migraine; and gastrointestinal disease, including celiac disease.
Our Science
We are pursuing novel approaches to discovering medicines for metabolic conditions, neurological disorders, and gastrointestinal disease.
Our Klarity™ platform utilizes a broad set of integrated technologies to obtain a more comprehensive understanding of the biology of the gut and signaling pathways between the gut and other organs.
